Copyright © 2013 Albuquerque Journal
Dr. Mitchell H. Gold, a nationally recognized pioneer in emerging cancer-fighting therapies, is throwing his weight behind a new, homegrown New Mexico technology that he believes could be a “game changer” in the battle against cancer.
The doctor, who helped usher in a new therapy for prostate cancer in 2010, is now working with researchers from the University of New Mexico and Sandia National Laboratories to commercialize a novel drug-delivery system that could make chemotherapy more effective while potentially eliminating toxic side effects.
The technology, known as the “protocell,” uses man-made nanoparticles to inject huge doses of cancer-killing drugs directly into the heart of tumors without harming healthy tissue.
Gold’s biotech investment firm, Alpine Biosciences, has acquired an option to license the protocell technology. It’s now setting up a local office to begin the commercialization process, and it’s planning a funding drive to raise up to $3 million in venture capital in the next six months.
Support your local Albuquerque Journal & Kevin Robinson-Avila SUBSCRIBE NOW cancel anytime